What's in Azienda Ospedaliero Universitaria di Sassari's pipeline?

Azienda Ospedaliero Universitaria di Sassari has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Azienda Ospedaliero Universitaria di Sassari's portfolio?

Top competitors by shared drug class: Organon and Co, Sheba Medical Center, Sheffield Teaching Hospitals NHS Foundation Trust, University of Texas Southwestern Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/azienda-ospedaliero-universitaria-di-sassari.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Azienda Ospedaliero Universitaria di Sassari — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azienda Ospedaliero Universitaria di Sassari pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
EZE/simvastatin	EZE/simvastatin	marketed	Combination lipid-lowering agent (ezetimibe + statin)	NPC1L1 transporter (ezetimibe); HMG-CoA reductase (simvastatin)	Cardiovascular
Ticagrelor standard tablets	Ticagrelor standard tablets	phase 3	P2Y12 receptor antagonist (antiplatelet agent)	P2Y12 receptor	Cardiovascular
Ticagrelor orodispersible tablets	Ticagrelor orodispersible tablets	phase 3	P2Y12 receptor antagonist (antiplatelet agent)	P2Y12 receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Organon and Co · 1 shared drug class
Sheba Medical Center · 1 shared drug class
Sheffield Teaching Hospitals NHS Foundation Trust · 1 shared drug class
University of Texas Southwestern Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Azienda Ospedaliero Universitaria di Sassari:

Cite this brief

Drug Landscape (2026). Azienda Ospedaliero Universitaria di Sassari — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/azienda-ospedaliero-universitaria-di-sassari. Accessed 2026-05-18.